Introduction
============

Childhood obesity is a prevalent disease worldwide ([@b1-mmr-17-01-0109])and has been recognized as a serious public health concern due to its increasing morbidity in addition to adverse health effects ([@b2-mmr-17-01-0109]). Compared with normal-weight children, obese children have an increased probability of obesity in adulthood ([@b3-mmr-17-01-0109]), which may lead to hypertension, diabetes, dyslipidemia, chronic heart disease and other disorders ([@b4-mmr-17-01-0109]). In addition, the prevalence of depression in obese children is greater than those of normal-weight children ([@b5-mmr-17-01-0109]).

Obesity in children is a multifactorial disease, to which numerous genetic factors contribute ([@b6-mmr-17-01-0109]). Previous genetic studies have identified that the mutation in melanocortin-4 receptor (*MC4R*) is associated with childhood obesity through binding with α-melanocyte-stimulating hormone (α-MSH). It has been identified that α-MSH could inhibit feeding, thus leading to an increasing risk of obesity ([@b7-mmr-17-01-0109]--[@b10-mmr-17-01-0109]). A missense amino acid substitution (*R236G*) has been reported to contribute to an inherited susceptibility to obesity. The *R236G* mutation contributes to an aberrant fusion protein, which is capable of interfering with central melanocortin signaling and appears to increase the risk of early-onset obesity ([@b11-mmr-17-01-0109]--[@b13-mmr-17-01-0109]). The fat mass and obesity associated gene has been recognized as another gene relevant to childhood obesity by influencing appetite and body composition ([@b14-mmr-17-01-0109],[@b15-mmr-17-01-0109]). However, the effective approaches of preventing obesity development in children remain limited and further studies of the molecular mechanisms are required.

The aim of the present study was to identify potential biomarkers of childhood obesity. Furthermore, the current study aimed to elucidate the molecular mechanism for the therapy of childhood obesity. The significant differentially expressed genes (DEGs) in omental adipose tissues were screened by comparison of samples between obese and normal-weight children with two-way hierarchical clustering, co-expression (CE) analysis and gene network construction. The notable amino acids were identified by measuring of codon usage bias.

Materials and methods
=====================

### Source of data

The microarray expression profile of GSE9624 (<http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE9624>) was extracted from the Gene Expression Omnibus database, based on the Affymetrix Human Genome U133 Plus 2.0 Array GPL570 (HG-U133_Plus_2). The data used was originally from 11 samples of omental adipose tissues, with 5 from obese children and 6 from normal-weight children.

### Data preprocessing and DEGs analysis

The probe-level data in the CEL files were converted into expression measures using the Affy package (version 1.48.0) ([@b16-mmr-17-01-0109]) with R software (<https://www.r-project.org/>). Missing data were inputted and data normalization was performed using quartile normalization ([@b17-mmr-17-01-0109]). A boxplot graph was produced to present the chip data distribution and the median values. When the median values were consistent subsequent to normalization, the chip data were used for DEGs analysis.

The omental adipose tissues of normal-weight children were considered as the controls. DEGs in omental adipose tissues between obese children samples and normal controls were identified by the limma package (version 3.26.8) (<https://bioconductor.org/packages/release/bioc/html/limma.html>) ([@b18-mmr-17-01-0109]). The P-values and log fold change (logFC) were calculated. P\<0.01 and \|logFC\| \>1 were considered as the cut-off criteria.

### Hierarchical clustering of DEGs

Two-way hierarchical clustering was applied using the pheatmap package in R language (version 1.0.8) (<https://cran.r-project.org/web/packages/pheatmap/index.html>) ([@b19-mmr-17-01-0109]). Subsequently, the heat map of the DEGs was generated. The clustering was performed using the Euclidean distance and Ward\'s method ([@b20-mmr-17-01-0109]).

### CE analysis of DEGs

The CE analysis was performed using online CoExpress software (<http://www.bioinformatics.lu/CoExpress/>). To identify CE DEGs, the correlation coefficient of each gene pair was calculated using the Pearson\'s correlation coefficient ([@b21-mmr-17-01-0109]). The correlation coefficient ranged from −1 to +1, '−' represented a negative correlation and '+ represented a positive correlation. When CE\<0.95, the gene pairs were cut off. Subsequently, the CE gene network was constructed by connecting the CE genes with straight lines.

### Gene network construction

The functional similarity of DEGs was calculated using GOSim package (version 1.8.0) (<https://www.bioconductor.org/packages/release/bioc/html/GOSim.html>) ([@b22-mmr-17-01-0109]), which functions based on various information theoretic similarity concepts for gene ontology (GO) terms. P\<0.05 was used as the cut-off criterion.

Following functional classification, the gene network enriched by the screened DEGs was constructed. The Cytoscape package (version 3.2.1) (<http://www.cytoscape.org/>) was applied for the network visualization ([@b23-mmr-17-01-0109]).

### Measures of codon usage bias

It has been previously identified that there are large differences in codon usage bias among genes with different functions ([@b24-mmr-17-01-0109]). The program of codon usage analysis has been previously used for analyzing codon and amino acid usage patterns ([@b25-mmr-17-01-0109]). In the current study, the codon usage bias of the DEGs in each cluster was examined using the codon adaptation index (CAI) value, which was calculated with the CAI program from the European Molecular Biology Open Software Suite (version 6.5.0) (<http://emboss.sourceforge.net/index.html>) ([@b26-mmr-17-01-0109]). CAI values between 0 and 1 indicated a positive correlation between the codon usage bias and the CAI value.

Results
=======

### DEGs analysis

The boxplot graph demonstrated that the chip data had been normalized and were available for DEGs selection ([Fig. 1](#f1-mmr-17-01-0109){ref-type="fig"}).

Based on the cut-off criteria of P\<0.01 and \|log FC\| \>1, 583 DEGs were identified in omental adipose tissues between the samples from obese children and those of normal-weight controls, including 310 upregulated genes and 273 downregulated genes.

### Hierarchical clustering of DEGs

The heat map of DEGs ([Fig. 2](#f2-mmr-17-01-0109){ref-type="fig"}) indicated a marked difference in the DEGs of omental adipose tissues between the samples from obese children and those of normal-weight controls, observed by the clear color difference.

### CE analysis of DEGs

A total of 130 DEGs were selected using the cut-off criterion of CE\>0.95. The CE network of those DEGs is presented in [Fig. 3](#f3-mmr-17-01-0109){ref-type="fig"}.

### Gene network construction

Functional classification of the 130 DEGs was performed. According to the GO functional nodes of these DEGs, they were classified into 4 clusters (summarized in [Table I](#tI-mmr-17-01-0109){ref-type="table"}).

The gene network of the DEGs with similarities of expression and function is presented in [Fig. 4](#f4-mmr-17-01-0109){ref-type="fig"}. The gene network included 38 nodes, 34 DEGs and 35 edges. There were 3 significantly upregulated genes \[microtubule-associated protein tau (*MAPT*), destrin (actin depolymerizing factor) (*DSTN*) and spectrin, β, non-erythrocytic 1 (*SPTBN1*)\] and 2 significantly downregulated genes \[Rho/Rac guanine nucleotide exchange factor 2 (*ARHGEF2*) and spindle and kinetochore associated complex subunit 1 (*SKA1*)\].

### Codon usage bias

The CAI values of the DEGs in the 4 clusters were 0.724 (cluster 1), 0.687 (cluster 2), 0.712 (cluster 3) and 0.705 (cluster 4), indicating a significant codon usage bias. To confirm the codon usage bias, amino acids translated by the codon in each sequence were summarized in [Table II](#tII-mmr-17-01-0109){ref-type="table"}. The top 3 amino acids were glycine, leucine and serine, which exhibited a high bias.

Discussion
==========

Childhood obesity is a multisystem disease with potentially life-threatening consequences ([@b27-mmr-17-01-0109]). In spite of numerous genetic studies aiming to elucidate the pathogenesis of childhood obesity, the molecular mechanisms in the development and progression of this disease remain unclear. In the present study, 3 notably upregulated genes (*MAPT*, *DSTN* and *SPTBN1*) and 2 notable downregulated genes (*ARHGEF2* and *SKA1*) were identified. Several functions, including microtubule polymerization or depolymerization, condensed chromosome kinetochore, regulation of cytoskeleton organization and regulation of microtubule cytoskeleton organization, were observed to be significantly enriched by these DEGs.

*SKA1* is a protein-coding gene. The *SKA1* complex is part of the conserved kinetochore-microtubule interface and directly associates with microtubules as part of oligomeric assemblies. It has been previously demonstrated to serve a critical role in interacting with dynamic microtubules at the outer kinetochore by depolymerizing microtubule ends ([@b28-mmr-17-01-0109]). As presented in [Table I](#tI-mmr-17-01-0109){ref-type="table"} and [Fig. 4](#f4-mmr-17-01-0109){ref-type="fig"}, *SKA1* was significantly enriched in regulation of microtubule polymerization or depolymerization. The depolymerizing microtubules attached by macromolecular kinetochores are necessary for the chromosome movements to ensure regular chromosome segregation ([@b29-mmr-17-01-0109],[@b30-mmr-17-01-0109]). Notably, *SKA1* was observed in the current study to also be enriched in cluster 4, which consisted of biological functions such as condensed chromosome kinetochore. Previous studies have identified that chromosomal (such as those on chromosome 11p14-p12 and chromosome 16p11.2) deletions may result in obesity ([@b31-mmr-17-01-0109]--[@b34-mmr-17-01-0109]). Therefore, it is suggested that *SKA1* may be associated with childhood obesity by depolymerizing microtubules and disturbing chromosome segregation.

An additional significantly downregulated gene identified in the present study is *ARHGEF2*. *ARHGEF2* encodes guanine nucleotide exchange factor H1, which is a microtubule-associated exchange factor ([@b35-mmr-17-01-0109],[@b36-mmr-17-01-0109]). *ARHGEF2* activity is downregulated by interaction of its C-terminus with microtubules ([@b37-mmr-17-01-0109]). Rho GEF is associated with microtubules and becomes active upon microtubule depolymerization ([@b38-mmr-17-01-0109]). Through functional analysis, *ARHGEF2* was observed to be significantly enriched in the regulation of microtubule polymerization or depolymerization. Hence, similar to that of *SKA1*, it is suggested that *ARHGEF2* may be a candidate gene in childhood obesity, acting via targeting the regulation of microtubule polymerization or depolymerization.

In the present study, *MAPT* was observed as a significantly upregulated gene. *MAPT* encodes the microtubule-associated protein (MAP) tau. MAP has been observed to serve an important role in the promotion of microtubule assembly *in vitro* ([@b39-mmr-17-01-0109]). The results of the current study indicated that *MAPT* targeted regulation of microtubule cytoskeleton organization. Previous studies have demonstrated that disruption of microtubule assembly inhibited the translocation of the insulin responsive glucose transporter isoform (*GLUT4*) ([@b40-mmr-17-01-0109],[@b41-mmr-17-01-0109]). *GLUT4* translocation promotes insulin to stimulate glucose uptake in adipose tissue, ultimately resulting in obesity ([@b42-mmr-17-01-0109]). Thus, *MAPT* may serve a stimulative role in the development and progression of childhood obesity.

*SPTBN1* is a member of the β-spectrin gene family ([@b43-mmr-17-01-0109]). Spectrin is a protein functioning in actin cross-linking and the molecular scaffold. It connects the plasma membrane to the actin cytoskeleton and determines cytoskeleton organization including cell shape, arrangement of transmembrane proteins and organization of organelles ([@b44-mmr-17-01-0109]). *SPTBN1* was identified in the current study as a significantly upregulated gene, enriched in pathway of regulation of cytoskeleton organization. Cytoskeleton organization is a biological process involving various cellular components in adipose tissues. Fat deposition in mature fat cells and cell proliferation have been suggested to accelerate pre-adipocytes to differentiate into adipocytes, serving a role in the regulation of body weight ([@b45-mmr-17-01-0109]). Thus, it is suggested that *SPTBN1* may be a candidate gene for childhood obesity, acting via the regulation of cytoskeleton organization function.

*DSTN* encodes for the protein destrin. Destrin is a pH-independent protein, with the capacity to sever actin filaments (F-actin) ([@b46-mmr-17-01-0109]). Destrin has been previously reported to serve a role in the reorganization of the actin cytoskeleton in response to stress and cell stimuli ([@b47-mmr-17-01-0109]). In addition, destrin belongs to the actin-depolymerizing factor family, which mediates a pH-sensitive destruction of actin filaments ([@b48-mmr-17-01-0109]--[@b51-mmr-17-01-0109]). Filament networks, such as peripheral actin filaments, have been identified to have a mechanical connection to various cytoskeletal structures ([@b52-mmr-17-01-0109]). By reviewing the functional classifications and the gene network in the current study, it is suggested that *DSTN* participates in the regulation of cytoskeletal organization. Previously, organization of the actin cytoskeleton was suggested to be necessary for early adipocyte differentiation, resulting in hyperplasia of adipose tissues which is a critical event for the development of obesity ([@b53-mmr-17-01-0109],[@b54-mmr-17-01-0109]). This led to it being hypothesized that *DSTN* may be a biomarkers of childhood obesity.

However, there were limitations in the present study. The results obtained were web-based and were not verified by any biological experiments. In addition, the data downloaded were from a European database, it remains unclear whether these results would be consistent for children from other continents. Thus, further experimental studies based on the observations of the current study are required.

In conclusion, *MAPT*, *DSTN*, *SPTBN1*, *ARHGEF2* and *SKA1* may be candidate biomarkers of childhood obesity. Microtubule polymerization or depolymerization, condensed chromosome kinetochore, regulation of cytoskeleton organization and regulation of microtubule cytoskeleton organization may be important biological pathways in the progression of childhood obesity. The observations of the current study may have implications for the understanding of the molecular mechanisms, and identification of candidate therapeutic agents, for childhood obesity. However, further studies are required to confirm the preliminary observations outlined in the current study, with the aim of this information being used in a clinical setting.

The current study was supported by the Shanghai Universities Young Teachers Training Scheme (grant no. Zzjdyx12021).

![Boxplot graph of chip data distribution. The data were normalized and available for differentially expressed gene selection. The pink and white boxes represent samples of omental adipose tissues in obese and normal children, respectively. The x-axis represents samples; the y-axis represents gene expression values. The black horizontal line in each box represents the median value of the chip data, and the median indicates the gene expression value subsequent to normalization.](MMR-17-01-0109-g00){#f1-mmr-17-01-0109}

![Heat map of differentially expressed genes. Red indicates high expression and blue indicates low expression. The color change from blue to red indicates movement from low to high levels of expression.](MMR-17-01-0109-g01){#f2-mmr-17-01-0109}

![Co-expression network of the differentially expressed genes. The downward and upward triangles refer to down- and upregulated genes, respectively. The edges represent the interactions.](MMR-17-01-0109-g02){#f3-mmr-17-01-0109}

![Gene network of differentially expressed genes with similarity of expression and function. The downward and upward triangles refer to down- and upregulated genes, respectively. The red circular nodes represent functional clusters. The edges represent the interactions.](MMR-17-01-0109-g03){#f4-mmr-17-01-0109}

###### 

Functional classification of correlated differentially expressed genes.

  Cluster name   Genes                                                                   Enrichment P-value   Biological function
  -------------- ----------------------------------------------------------------------- -------------------- --------------------------------------------------------------------------
  C1 (BP)        *ARHGEF2, MAPT, SPTBN1, SKA1, DSTN*                                     0.0154               GO:0051493\~regulation of cytoskeleton organization
                 *ARHGEF2, MAPT, SKA1*                                                   0.0199               GO:0031110\~regulation of microtubule polymerization or depolymerization
                 *ARHGEF2, MAPT, SKA1*                                                   0.0350               GO:0070507\~regulation of microtubule cytoskeleton organization
                 *ARHGEF2, MAPT, SKA1*                                                   0.0464               GO:0032886\~regulation of microtubule-based process
  C2 (BP)        *ARHGEF2, MAPT, EIF5A, SPTBN1, DSTN*                                    0.0004               GO:0043244\~regulation of protein complex disassembly
                 *ARHGEF2, MAPT, SPTBN1, SKA1, DSTN*                                     0.0154               GO:0051493\~regulation of cytoskeleton organization
                 *ARHGEF2, MAPT, SPTBN1*                                                 0.0335               GO:0043242\~negative regulation of protein complex disassembly
  C3 (BP)        *NRP2, LEP, SLITRK3, IRX5, EFNA2, EPHB3, SNAP25 NRP2, SLITRK3, EFNA2*   0.0320               GO:0048666\~neuron development
                 *EPHB3, SNAP25*                                                         0.0469               GO:0007409\~axonogenesis
  C4 (CC)        *CENPN, CENPM, SKA1*                                                    0.0064               GO:0000777\~condensed chromosome kinetochore
                 *CENPN*, CENPM, SKA1                                                    0.0080               GO:0000779\~condensed chromosome, centromeric region
                 *CENPN, CENPM, SKA1*                                                    0.0104               GO:0000776\~kinetochore
                 *CENPN, CENPM, SKA1*                                                    0.0221               GO:0000775\~chromosome, centromeric region
                 *CENPN, CENPM, SKA1*                                                    0.0234               GO:0000793\~condensed chromosome

BP, biological process; GO, gene ontology; C1-4, cluster 1--4; CC, cellular component; ARHGEF, 2 Rho/Rac guanine nucleotide exchange factor 2; MAPT, microtubule-associated protein tau; SPTBN1, spectrin, β, non-erythrocytic 1; SKA1, spindle and kinetochore associated complex subunit 1; DSTN, destrin (actin depolymerizing factor); EIF5A, eukaryotic translation initiation factor 5A-1; NRP2, neuropilin 2; LEP, leptin; SLITRK3, SLIT and NTRK-like family member 3; IRX5, iroquois homeobox 5; EFNA2, ephrin-A2; EPHB3, ephrin type-B receptor 3; SNAP25, synaptosomal-associated protein 25; CENPN, centromere protein N; CENPM, centromere protein M.

###### 

Codon usage of differential expression genes sequence in the 4 clusters.

        AA Sum                                                   
  ----- -------- ------ ----- ------ ------ ------ ------ ------ ------
  GCA   A        194    26    695    190    712    148    2147   666
  GCC   A        253    40    641    210                         
  GCG   A          45   48    163      58                        
  GCT   A        220    34    648    208                         
  TGC   C        212    24    771    198    376      51   1579   427
  TGT   C        164    27    808    229                         
  GAC   D        128    20    469    117    270      40   1058   255
  GAT   D        142    20    589    138                         
  GAA   E        212    18    880    187    573      60   1731   436
  GAG   E        361    42    851    249                         
  TTC   F        203    46    857    216    531    108    2242   616
  TTT   F        328    62    1385   400                         
  GGA   G        281    46    842    198    1146   185    2907   765
  GGC   G        255    43    658    203                         
  GGG   G        387    62    825    180                         
  GGT   G        223    34    582    184                         
  CAC   H        179    22    693    200    341      43   1519   355
  CAT   H        162    21    826    155                         
  ATA   I        114    11    752    171    406      52   2302   528
  ATC   I        127    19    605    153                         
  ATT   I        165    22    945    204                         
  AAA   K        294    18    1478   406    491      44   2328   609
  AAG   K        197    26    850    203                         
  CTA   L        134    18    470    136    1322   212    4625   1282
  CTC   L        275    49    804    249                         
  CTG   L        372    42    958    288                         
  CTT   L        220    45    851    230                         
  TTA   L        135    21    778    173                         
  TTG   L        186    37    764    206                         
  ATG   M        165    22    776    183    165      22   776    183
  AAC   N        109    10    617    163    244      22   1550   384
  AAT   N        135    12    933    221                         
  CCA   P        273    35    880    214    1029   157    2750   682
  CCC   P        339    57    831    170                         
  CCG   P          86   17    213      69                        
  CCT   P        331    48    826    229                         
  CAA   Q        178    24    832    177    495      60   1815   448
  CAG   Q        317    36    983    271                         
  AGA   R        289    30    1020   228    846    137    2503   663
  AGG   R        337    41    843    233                         
  CGA   R          35     9   128      48                        
  CGC   R          64   16    143      58                        
  CGG   R          80   28    233      51                        
  CGT   R          41   13    136      45                        
  AGC   S        264    30    662    194    1235   182    3930   1118
  AGT   S        207    23    666    188                         
  TCA   S        191    31    795    227                         
  TCC   S        252    44    771    202                         
  TCG   S          47   12    126      40                        
  TCT   S        274    42    910    267                         
  ACA   T        164    12    845    206    538      72   2187   587
  ACC   T        197    25    564    134                         
  ACG   T          33   10    131      54                        
  ACT   T        144    25    647    193                         
  GTA   V        124    13    435    136    642    112    2144   634
  GTC   V        136    24    433    126                         
  GTG   V        246    39    680    212                         
  GTT   V        136    36    596    160                         
  TGG   W        331    42    945    233    331      42   945    233
  TAC   Y          95   11    397    132    179      24   1090   305
  TAT   Y          84   13    693    173                         
  TAA   \*       108      9   819    214                         
  TAG   \*       134    17    526    149                         
  TGA   \*       208    22    827    206                         

Columns 3--6 indicate the number of codons of the differentially expressed genes in each cluster. The last column shows the number of AA encoded by different codons. \*No corresponding amino acid. AA, amino acid; A, alanine; C, cysteine; D, aspartate; E, glutamate; F, phenylalanine; G, glycine; H, histidine; I, isoleucine; K, lysine; L, leucine; M, methionine; N, asparagine; P, proline; Q, glutamine; R, arginine; S, serine; T, threonine; V, valine; W, tryptophan; Y, tyrosine.
